005690.KS
Pharmicell Co., Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 10,380.00
−1.61%Leverage
- Debt / equity
- 0.18x
- Net debt / equity
- 0.07x
- Debt / assets
- 0.14x
- Debt / EBITDA
- 0.54x
- Net debt / EBITDA
- 0.22x
Liquidity & coverage
- Current ratio
- 7.15x
- Quick ratio
- 6.01x
- Cash ratio
- 4.09x
- Interest coverage
- 45.00x
- EBITDA / interest
- 48.04x
- Working capital
- KRW 98.7B
Cash & dividend
- FCF / debt
- 1.02x
- Cash flow / debt
- 1.61x
- Dividend per share
- KRW 50
- Dividend yield
- 0.5%
- Dividend growth 1y
- +150.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026